ArticleCommunications biology2025

Isoacteoside alleviates hepatocellular carcinoma progression by inhibiting PDHB-mediated reprogramming of glucose metabolism.

Lijun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.